Anle138b

CAT: 0400-SIH-607-5MGSize: 5 mgDry Ice: NoHazardous: No
CAT#:0400-SIH-607-5MGSize:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Background
Anle138b is an oligomeric aggregation inhibitor that inhibits the formation of pathological prion protein (PrPSc) and α-synuclein aggregates in vitro. Anle138b prevents accumulation of PrPSc in the brain and the spleen. Anle138b exhibits neuroprotective effects in a Parkinson's disease mouse model and improves motor performance in an α-synucleinopathy model.
Description
Synuclein aggregation inhibitor
CAS Number
882697-00-9
Product Name Alternative
3- (1,3-Benzodioxol-5-yl) -5- (3-bromophenyl) -1H-pyrazole, 5- (1,3-Benzodioxol-5-yl) -3- (3-bromophenyl) -1H-pyrazole, Anle 138b, CID 44608289
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Neuroscience | Neurodegeneration | Parkinson's Disease | Synuclein
Purity
>98% (HPLC) ; NMR (Conforms)
Weight
0.005
Format
White powder
Solubility
May be dissolved in DMSO (15 mg/ml, warm)
Molecular Formula
C16H11BrN2O2
Molecular Weight
343.2
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Wagner J. et al. (2013) Acta Neuropathol. 125 (6): 795-813.

Alternative Products

CatalogName
S6782-5mgAnle138b
HY-161746-01Anle138b-F105
A20001-10Anle138b 10mg
A20001-5Anle138b 5mg
A20001-50Anle138b 50mg
A20001-100Anle138b 100mg
A20001-200Emrusolmin (Anle138b) 200mg
A20001-25Emrusolmin (Anle138b) 25mg
TBI4945-25MGAnle138b, Protein aggregation inhibitor
A20001-10mM-DEmrusolmin (Anle138b) 10mM * 1mL in DMSO

Popular Products